US court fines Indian publisher of predatory journals $50m

31 August, 2019 [*see note below]

Best regards.

Najeeb Al-Shorbaji, PhD, FIAHSI

President of the eHealth Development Association of Jordan,

Independent Consultant in Knowledge Management and eHealth,

e-Marefa Advisor

P.O. Box 542006

Amman 11937


Mobile +962 799391604

Tel. +962 (6) 5240273


Twitter: shorbajin


HIFA profile: Najeeb Al-Shorbaji recently retired from the World Health Organization (WHO), where he has worked since 1988 in different capacities. He was most recently Director of the Knowledge, Ethics and Research Department at WHO headquarters, Geneva. Previously he was Coordinator for Knowledge Management and Sharing in EMRO (Eastern Mediterranean Regional Office), Egypt. He is a member of a number of national and international professional societies and associations specialised in information management and health informatics. He has authored over 100 research papers and articles presented in various conferences and published in professional journals. He is a member of the HIFA Steering Group and the HIFA Working Group on Multilingualism.

Email: shorbajin AT

[*Note from HIFA moderator (Neil PW): For the benefit of those who may not have immediate web access, here are extracts:

The Federal Trade Commission has... won a $50 million court judgment against Omics International of Hyderabad, India, and its owner, Srinubabu Gedela.

Omics publishes hundreds of journals in such areas as medicine, chemistry and engineering. It also organises conferences. The FTC claimed that Omics violated the agency’s prohibition on deceptive business practices. In addition to the judgment, a federal judge in Nevada — where Omics has mail drops — ordered the company to cease its deceptive business practices, including failing to disclose fees, misleading authors about the legitimacy of its journals and marketing conferences with star speakers who never agreed to participate...

It was the huge amount of money rolling into Omics that led the FTC to request a $50 million judgment. That is the amount that Omics netted from its customers between August 25, 2011, and July 31, 2017, the agency said. “The court agreed with us that their deceptive practices are so widespread that this represents full consumer redress, and the court did not dial it back,” Ashe said.]